HIGHLIGHTS
- who: HYPOTHESIS and collaborators from the Unit of Clinical, University Hospital Agency of Cagliari, Cagliari, Italy, Department of Biomedical Sciences, Division have published the research work: Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology, in the Journal: (JOURNAL)
SUMMARY
The two studies agree with the increase of fundamentals type 2 cytokines, like IL-5 and IL-13 in severe COVID-19 patients, at least in a subset of them (Lucas et_al, 2020; Mathew et_al, 2020). In the last phase of a severe course, the immune . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.